• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Mural Oncology plc - Ordinary Shares (NQ: MURA )

    3.180 -0.060 (-1.85%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 188,691
    Open 3.230
    Bid (Size) 3.170 (5)
    Ask (Size) 3.480 (1)
    Prev. Close 3.240
    Today's Range 3.080 - 3.370
    52wk Range 2.870 - 6.250
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga

    Performance

    YTD
    -46.82%
    -46.82%
    1 Month
    -19.08%
    -19.08%
    3 Month
    +4.95%
    +4.95%
    6 Month
    +3.58%
    +3.58%
    1 Year
    -42.70%
    -42.70%

    More News

    Read More
    Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology to Participate in Two Upcoming Investor Conferences
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    This MINISO Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology to Host First Virtual Investor Day on September 26, 2024
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology to Present at Two Upcoming Investor Conferences
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Why Workday Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    MURA Stock Earnings: Mural Oncology Beats EPS for Q2 2024
    Via InvestorPlace
    Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
    From Mural Oncology, Inc.
    Via GlobeNewswire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.